Waystar (NASDAQ:WAY - Get Free Report) had its price objective hoisted by Canaccord Genuity Group from $30.00 to $36.00 in a report issued on Thursday,Benzinga reports. The brokerage presently has a "buy" rating on the stock. Canaccord Genuity Group's price objective points to a potential upside of 12.46% from the stock's current price.
A number of other analysts have also issued reports on the stock. The Goldman Sachs Group lifted their price target on shares of Waystar from $34.00 to $39.00 and gave the stock a "buy" rating in a research note on Thursday. Bank of America raised their target price on Waystar from $27.00 to $32.00 and gave the company a "buy" rating in a research report on Monday, October 14th. JPMorgan Chase & Co. upped their price target on shares of Waystar from $24.00 to $27.00 and gave the stock an "overweight" rating in a research note on Monday, August 19th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Waystar from $27.00 to $31.00 and gave the company a "buy" rating in a research note on Wednesday, August 14th. Finally, Royal Bank of Canada lifted their price target on Waystar from $31.00 to $34.00 and gave the company an "outperform" rating in a research report on Thursday. Eleven investment analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average price target of $31.90.
Read Our Latest Stock Report on Waystar
Waystar Stock Performance
Shares of NASDAQ:WAY traded up $2.57 during trading on Thursday, reaching $32.01. The stock had a trading volume of 3,163,107 shares, compared to its average volume of 851,863. The company has a debt-to-equity ratio of 0.46, a current ratio of 2.15 and a quick ratio of 2.15. Waystar has a fifty-two week low of $20.26 and a fifty-two week high of $33.25. The firm's fifty day moving average is $27.47.
Waystar (NASDAQ:WAY - Get Free Report) last announced its quarterly earnings results on Wednesday, August 7th. The company reported $0.04 EPS for the quarter, topping the consensus estimate of ($0.01) by $0.05. The firm had revenue of $234.50 million for the quarter, compared to analyst estimates of $216.25 million. During the same quarter in the prior year, the company earned ($0.07) earnings per share. The business's revenue was up 19.6% compared to the same quarter last year. On average, equities analysts expect that Waystar will post -0.08 EPS for the current year.
Hedge Funds Weigh In On Waystar
Several large investors have recently bought and sold shares of the company. Amalgamated Bank purchased a new stake in shares of Waystar during the 3rd quarter valued at $41,000. RiverPark Advisors LLC purchased a new position in shares of Waystar in the third quarter worth about $78,000. Cubist Systematic Strategies LLC purchased a new stake in shares of Waystar during the second quarter valued at approximately $145,000. Scientech Research LLC bought a new position in shares of Waystar during the second quarter valued at about $289,000. Finally, Federated Hermes Inc. purchased a new stake in Waystar in the second quarter worth about $430,000.
About Waystar
(
Get Free Report)
Waystar Holding Corp. is a software company which provide healthcare payments. Waystar Holding Corp. is based in LEHI, Utah.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Waystar, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waystar wasn't on the list.
While Waystar currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.